Cronos Group (NASDAQ:CRON) Trading 5.8% Higher

Share on StockTwits

Cronos Group Inc (NASDAQ:CRON)’s stock price shot up 5.8% during trading on Tuesday . The company traded as high as $6.90 and last traded at $6.88, 6,326,716 shares traded hands during trading. A decline of 25% from the average session volume of 8,424,857 shares. The stock had previously closed at $6.50.

Several brokerages have recently commented on CRON. BMO Capital Markets upgraded Cronos Group from an “underperform” rating to a “market perform” rating in a research report on Thursday, September 5th. Zacks Investment Research lowered Cronos Group from a “buy” rating to a “hold” rating in a research report on Wednesday, November 13th. Canaccord Genuity upgraded Cronos Group from a “sell” rating to a “hold” rating and raised their price objective for the stock from $16.00 to $17.00 in a research note on Friday, August 9th. Stifel Nicolaus raised shares of Cronos Group from a “hold” rating to a “buy” rating and decreased their price objective for the stock from $16.50 to $14.00 in a report on Friday, October 18th. Finally, ValuEngine upgraded shares of Cronos Group from a “hold” rating to a “buy” rating in a research note on Tuesday. One analyst has rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the company’s stock. Cronos Group presently has an average rating of “Hold” and a consensus price target of $17.27.

The company has a fifty day moving average price of $7.77 and a 200 day moving average price of $11.90. The company has a market capitalization of $2.31 billion, a P/E ratio of -86.00 and a beta of 3.20.

Cronos Group (NASDAQ:CRON) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.01. Cronos Group had a return on equity of 31.88% and a net margin of 4,086.41%. The business had revenue of $10.10 million for the quarter, compared to the consensus estimate of $10.42 million. Sell-side analysts expect that Cronos Group Inc will post -0.09 EPS for the current year.

A number of institutional investors and hedge funds have recently modified their holdings of CRON. Captrust Financial Advisors lifted its stake in Cronos Group by 7,925.0% in the second quarter. Captrust Financial Advisors now owns 1,605 shares of the company’s stock valued at $26,000 after buying an additional 1,585 shares during the last quarter. Commonwealth Bank of Australia bought a new position in shares of Cronos Group during the second quarter worth about $29,000. US Bancorp DE increased its holdings in shares of Cronos Group by 90.9% in the 2nd quarter. US Bancorp DE now owns 2,100 shares of the company’s stock worth $34,000 after acquiring an additional 1,000 shares during the period. Focused Wealth Management Inc increased its holdings in shares of Cronos Group by 102.4% in the 3rd quarter. Focused Wealth Management Inc now owns 3,756 shares of the company’s stock worth $34,000 after acquiring an additional 1,900 shares during the period. Finally, Resources Investment Advisors LLC. bought a new stake in Cronos Group in the 2nd quarter valued at about $38,000. Hedge funds and other institutional investors own 11.72% of the company’s stock.

Cronos Group Company Profile (NASDAQ:CRON)

Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada.

Read More: 52 Week Highs

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.